Capital Product Partners LP
NASDAQ:CPLP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Capital Product Partners LP
NASDAQ:CPLP
|
GR |
|
C
|
Cardiol Therapeutics Inc
NASDAQ:CRDL
|
CA |
|
P
|
Propel Funeral Partners Ltd
ASX:PFP
|
AU |
|
H
|
Huaxin Cement Co Ltd
SSE:600801
|
CN |
|
H
|
Hantop Inc
KOSDAQ:002680
|
KR |
|
Acea SpA
OTC:ACEJF
|
IT |
|
Komatsu Ltd
F:KOMA
|
JP |
|
M
|
Meta Platforms Inc
F:FB2A
|
US |
|
Omega Diagnostics Group PLC
LSE:ODX
|
UK |
|
A
|
AAPICO Hitech PCL
SET:AH
|
TH |
|
L
|
Lemonsoft Oyj
OMXH:LEMON
|
FI |
|
Cake Box Holdings PLC
LSE:CBOX
|
UK |
|
2
|
29Metals Ltd
ASX:29M
|
AU |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CPLP's stock price target?
Not Available
CPLP doesn't have any price targets made by Wall Street professionals.
What is Capital Product Partners LP's Revenue forecast?
Projected CAGR
20%
For the last 8 years the
compound annual growth rate for
Capital Product Partners LP's revenue is
6%.
The projected
CAGR
for the next 4 years is
20%.
What is Capital Product Partners LP's Operating Income forecast?
Projected CAGR
28%
For the last 8 years the
compound annual growth rate for
Capital Product Partners LP's operating income is
10%.
The projected
CAGR
for the next 4 years is
28%.
What is Capital Product Partners LP's Net Income forecast?
Projected CAGR
47%
For the last 8 years the
compound annual growth rate for
Capital Product Partners LP's net income is
1%.
The projected
CAGR
for the next 4 years is
47%.
